ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study
Clinical trial NCT06194799 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06194799
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-23
- Primary completion
- 2029-04-01
- Enrollment
- 752
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.